Longer white blood cells telomere length (a structure at the end of a chromosome) was associated with increased overall survival at 5 years among patients with severe aplastic anemia who received stem cell transplant from an unrelated donor reports a recent study.
Shahinaz M. Gadalla, M.D., Ph.D., of the National Cancer Institute, National Institutes of Health, Rockville, M.D. and colleagues studied the overall survival rate of patients with severe aplastic anemia who received stem cell transplant from an unrelated donor.
Aplastic Anemia
Aplastic anemia (AA) is a term that refers to a condition where the body fails to produce enough blood cells.
Advertisement
Telomeres protect chromosome ends and are essential for maintaining chromosomal stability. Telomere length is a biological marker for cellular aging and the capacity to replicate. Defects in telomere biology is one of the cause for aplastic anemia, a blood disorder where the bone marrow fails to make new blood cells.
Allogeneic hematopoietic cell transplantation (HCT) is recommended as initial therapy for young patients with acquired severe aplastic anemia when a matched sibling donor is available.
![Sickle Cell Anemia]( "Sickle Cell Anemia")
Sickle cell anemia (SCA) is a genetic blood disorder caused by abnormal inherited hemoglobin. Sickle cell anemia is the most common form of sickle cell disease.
The association between recipient and donor pre-transplant leukocyte telomere length with outcomes after unrelated donor allogeneic HCT for 330 patients with severe aplastic anemia was evaluated.
Patients who underwent HCT between 1989 and 2007 in 84 centers were followed up. Based on the leukocyte telomere length tertiles in the donors, leukocyte telomere length for both recipient and donor analyses was categorized as long and short.
The researchers found that longer donor leukocyte telomere length had 5-year overall survival of 56 percent compared to 40 percent in the short donor leukocyte telomere length group.
After adjusting for donor age and clinical factors associated with survival following HCT in severe aplastic anemia, the risk of post-HCT all-cause mortality remained approximately 40 percent lower in patients receiving HCT from donors with long verses short leukocyte telomere length.
Source: Medindia
Sickle Cell Anemia
Sickle cell anemia (SCA) is a genetic blood disorder caused by abnormal inherited hemoglobin. Sickle cell anemia is the most common form of sickle cell disease.
Advertisement
The association between recipient and donor pre-transplant leukocyte telomere length with outcomes after unrelated donor allogeneic HCT for 330 patients with severe aplastic anemia was evaluated.
Patients who underwent HCT between 1989 and 2007 in 84 centers were followed up. Based on the leukocyte telomere length tertiles in the donors, leukocyte telomere length for both recipient and donor analyses was categorized as long and short.
The researchers found that longer donor leukocyte telomere length had 5-year overall survival of 56 percent compared to 40 percent in the short donor leukocyte telomere length group.
After adjusting for donor age and clinical factors associated with survival following HCT in severe aplastic anemia, the risk of post-HCT all-cause mortality remained approximately 40 percent lower in patients receiving HCT from donors with long verses short leukocyte telomere length.
Source: Medindia
Anemia
Anemia is a condition in which the red blood cell (RBC) count or hemoglobin is less than normal.
Advertisement
 Diamond Blackfan AnemiaDiamond Blackfan Anemia (DBA) is a rare blood disorder first described in 1938 by two doctors at the Boston Children's Hospital, Kenneth Blackfan and Louis Diamond. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
